Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03678025 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 5 years later Apr 1, 2028 → Apr 1, 2033
See other at-risk trials from SWOG Cancer Research Network

Record History

  1. Primary completion pushed from Apr 1, 2028 to Apr 1, 2033 Completion pushed from Oct 1, 2031 to Oct 1, 2036 · Eligibility criteria expanded, about 24 words · Secondary endpoints: details revised at 2 of 3 entries · 1 more Show 4 more changesShow less
    • Completion pushed from Oct 1, 2031 to Oct 1, 2036
    • Eligibility criteria expanded, about 24 words
    • Secondary endpoints: details revised at 2 of 3 entries
    • Site details revised at 36 of 338 sites
  2. 2 versions Re-verified since Aug 14, 2024, no change to tracked fieldsv16-v17
  3. Study sites: 328 to 338v15
  4. Start date: Sep 17, 2018 to Sep 24, 2018v14
  5. Study sites: 326 to 328v13
Show 11 earlier versionsHide 11 earlier versions
  1. Study sites: 302 to 326v12
  2. Study sites: 276 to 302v11
  3. Study sites: 262 to 276v10
  4. Study sites: 257 to 262v9
  5. Study sites: 248 to 257v8
  6. Study sites: 140 to 248v7
  7. Re-verified, no change to tracked fieldsv6
  8. Study sites: 138 to 140v5
  9. Study sites: 117 to 138v4
  10. Study sites: 1 to 117v3
  11. Primary completion date: Apr 1, 2023 to Apr 1, 2028v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This phase III trial studies how well standard systemic therapy with or without definitive treatment (prostate removal surgery or radiation therapy) works in treating participants with prostate cancer that has spread to other places in the body. Addition of prostate removal surgery or radiation therapy to standard systemic therapy for prostate cancer may lower the chance of the cancer growing or spreading.
Trial Details
NCT Number NCT03678025
Lead Sponsor SWOG Cancer Research Network
Collaborators: National Cancer Institute (NCI)
Conditions Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma, Stage IV Prostate Cancer AJCC v8, Stage IVA Prostate Cancer AJCC v8, Stage IVB Prostate Cancer AJCC v8
Enrollment 1,273 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov